Dermatologic complications in transplantation and cellular therapy for acute leukemia Review


Authors: Babakoohi, S.; Gu, S. L.; Ehsan, H.; Markova, A.
Review Title: Dermatologic complications in transplantation and cellular therapy for acute leukemia
Abstract: Adoptive cellular immunotherapy, mainly hematopoietic stem cell transplant and CAR-T cell therapy have revolutionized treatment of patients with acute leukemia. Indications and inclusion criteria for these treatments have expanded in recent years. While these therapies are associated with significant improvements in disease response and overall survival, patients may experience adverse events from associated chemotherapy conditioning, engraftment, cytokine storm, supportive medications, and post-transplant maintenance targeted therapies. Supportive oncodermatology is a growing specialty to manage cutaneous toxicities resulting from the anti-cancer therapies. In this review, we summarize diagnosis and management of the common cutaneous adverse events including drug eruptions, graft-versus-host disease, neoplastic and paraneoplastic complications in patients undergoing cellular therapies. © 2023 Elsevier Ltd
Keywords: gvhd; drug eruptions; hematopoietic stem cell transplant; car-t cell therapy; dermatological complications
Journal Title: Best Practice and Research: Clinical Haematology
Volume: 36
Issue: 2
ISSN: 1521-6926
Publisher: Elsevier Inc.  
Date Published: 2023-06-01
Start Page: 101464
Language: English
DOI: 10.1016/j.beha.2023.101464
PROVIDER: scopus
DOI/URL:
Notes: The MSK Cancer Center Support Grant (P30 CA008748) is acknowledged in the PDF. Corresponding author is MSK author Alina Markova -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Alina Markova
    87 Markova
  2. Stephanie Gu
    15 Gu